◄ back to all posts
Financial data and stock pages provided by
Fintel.io
◄ back to all posts
JNJ: Johnson & Johnson Stock
Written by | Jul 6, 2018SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 430,552.35 |
Enterprise Value ($M) | 441,187.28 |
Book Value ($M) | 64,473.00 |
Book Value / Share | 24.49 |
Price / Book | 6.63 |
NCAV ($M) | -48,642.00 |
NCAV / Share | -18.48 |
Price / NCAV | -8.79 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.18 |
Return on Assets (ROA) | 0.10 |
Return on Equity (ROE) | 0.25 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.24 |
Current Ratio | 1.48 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 57,578.00 |
Assets | 170,693.00 |
Liabilities | 106,220.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | n/a |
Net Income | 15,119.00 |
Earnings Per Share Diluted | 5.63 |
Earnings Per Share Basic | 5.72 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 23,416.00 |
Cash from Investing | -6,194.00 |
Cash from Financing | -6,194.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | State Street Corp | 5.77 | 0.10 | |
13G/A | Vanguard Group Inc | 8.67 | 3.15 | |
13G/A | BlackRock Inc. | 7.30 | 5.06 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
Quarterly Report – 10-Q | ||
Quarterly Report – 10-Q | ||
Quarterly Report – 10-Q | ||
Annual Report – 10-K 2019 | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
942,959 | 8,137,000 | 11.59 | |
631,061 | 6,821,600 | 9.25 | |
620,152 | 6,839,800 | 9.07 | |
876,140 | 9,056,900 | 9.67 | |
(click for more detail) |
|||
(click for list of largest short owners) |
Similar Companies | |
---|---|
GSK – GlaxoSmithKline plc | HEXO – HEXO Corp. |
HSP – Hospira | LCI – Lannett Co., Inc. |
LLY – Eli Lilly & Co. |
Financial data and stock pages provided by
Fintel.io
2018/07/06